We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.14B
AUM Growth
+$728M
Cap. Flow
+$534M
Cap. Flow %
17.01%
Top 10 Hldgs %
37.86%
Holding
6,828
New
511
Increased
3,030
Reduced
2,253
Closed
625

Sector Composition

Rank Sector Weight
1 Technology 21.24%
2 Consumer Discretionary 7.38%
3 Financials 6.38%
4 Healthcare 5.93%
5 Industrials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TLRY icon
2876
Tilray
TLRY
$637M
$34K ﹤0.01%
1,358
-2,494
-65% -$71.2K
WEAV icon
2877
Weave Communications
WEAV
$428M
$34K ﹤0.01%
6,800
+3,236
+91% +$16.3K
VAXX
2878
DELISTED
Vaxxinity, Inc. Class A Common Stock
VAXX
$34K ﹤0.01%
14,962
+14,562
+3,641% +$36.9K
GHL
2879
DELISTED
Greenhill & Co., Inc.
GHL
$34K ﹤0.01%
3,859
+1,576
+69% +$17.9K
CAJ
2880
DELISTED
Canon, Inc.
CAJ
$34K ﹤0.01%
1,508
-3,053
-67% -$67K
ALEX
2881
DELISTED
Alexander & Baldwin
ALEX
$33K ﹤0.01%
1,752
+1,460
+500% +$27.7K
APPN icon
2882
Appian
APPN
$2.6B
$33K ﹤0.01%
738
-757
-51% -$30.6K
DCH
2883
Dauch Corp
DCH
$1.6B
$33K ﹤0.01%
4,246
+2,452
+137% +$21K
BIS icon
2884
ProShares UltraShort NASDAQ Biotechnology
BIS
$2.08M
$33K ﹤0.01%
+816
New +$32.5K
CENTA icon
2885
Central Garden & Pet Co Class A
CENTA
$2.4B
$33K ﹤0.01%
1,064
-13,469
-93% -$414K
CNTA
2886
DELISTED
Centessa Pharmaceuticals
CNTA
$33K ﹤0.01%
8,574
-7,597
-47% -$27.8K
COGT icon
2887
Cogent Biosciences
COGT
$6.38B
$33K ﹤0.01%
3,030
-88
-3% -$1.13K
CSGS
2888
DELISTED
CSG Systems International
CSGS
$33K ﹤0.01%
614
-3,201
-84% -$182K
DNUT icon
2889
Krispy Kreme
DNUT
$571M
$33K ﹤0.01%
2,113
+1,058
+100% +$13.7K
ENTG icon
2890
Entegris
ENTG
$24.6B
$33K ﹤0.01%
406
-29,732
-99% -$2.41M
ESPR
2891
DELISTED
Esperion Therapeutics
ESPR
$33K ﹤0.01%
20,907
+13,932
+200% +$71.9K
FWONA icon
2892
Liberty Media Series A
FWONA
$24B
$33K ﹤0.01%
520
-2,886
-85% -$174K
GANX icon
2893
Gain Therapeutics
GANX
$92.6M
$33K ﹤0.01%
6,844
-308
-4% -$1.26K
GHRS icon
2894
GH Research
GHRS
$1.98B
$33K ﹤0.01%
4,075
+2,898
+246% +$26.6K
GLP icon
2895
Global Partners
GLP
$1.72B
$33K ﹤0.01%
1,072
+728
+212% +$24.6K
GTES icon
2896
Gates Industrial Corporation Ltd.
GTES
$7.02B
$33K ﹤0.01%
2,354
+1,588
+207% +$21.2K
ISTB icon
2897
iShares Core 1-5 Year USD Bond ETF
ISTB
$5.14B
$33K ﹤0.01%
697
-3,683
-84% -$172K
IVW icon
2898
iShares S&P 500 Growth ETF
IVW
$77.9B
$33K ﹤0.01%
520
-3,725
-88% -$228K
MDV
2899
Modiv Industrial
MDV
$33K ﹤0.01%
3,352
+2,342
+232% +$25.6K
OEC icon
2900
Orion
OEC
$361M
$33K ﹤0.01%
1,267
+637
+101% +$14.4K

Similar funds

Tower Research Capital (TRC)'s Q1 2023 Portfolio in Review

As of Q1 2023, Tower Research Capital (TRC) held 6,828 positions worth $3.14B, up 30% from $2.41B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tower Research Capital (TRC) deployed $534M of net new capital in Q1 2023, opening 511 new positions and adding to 3,030 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $52.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2023 buy was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $52.8M.
  • Tower Research Capital (TRC) fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $7.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 38% of its $3.14B portfolio in Q1 2023.
  • Tower Research Capital (TRC) opened 511 new positions and closed 625 in Q1 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 30% quarter-over-quarter to $3.14B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.